Citius Oncology Inc
NASDAQ:CTOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Citius Oncology Inc
NASDAQ:CTOR
|
US |
|
Archtis Ltd
ASX:AR9
|
AU |
|
J
|
JD Food PCL
SET:JDF
|
TH |
|
T
|
Tempore Properties SOCIMI SAU
MAD:YTEM
|
ES |
|
MedMira Inc
XTSX:MIR
|
CA |
|
Wolters Kluwer NV
AEX:WKL
|
NL |
|
ITV PLC
LSE:ITV
|
UK |
|
Fabled Silver Gold Corp
XTSX:FCO
|
CA |
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
KR |
|
Ayala Corp
XPHS:AC
|
PH |
|
Upstream Bio Inc
NASDAQ:UPB
|
US |
|
K-Bro Linen Inc
TSX:KBL
|
CA |
|
ITM Power PLC
LSE:ITM
|
UK |
|
Beter Bed Holding NV
AEX:BBED
|
NL |
|
T
|
Thumbage Co Ltd
KOSDAQ:208640
|
KR |
Shareholder Yield
Current shareholder yield for CTOR is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CTOR Price
Citius Oncology Inc
| Average Annual Return | -97.06% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -99% |
| Market Capitalization | 59.6m USD |
| Shares Outstanding | 88 280 000 |
| Percentage of Shares Shorted | 4.69% |
